encapsulated cell therapy

Therapeutics The enclosing of cells capable of producing a desired substance, in a semipermeable nonimmunogenic sheath, to restore a lost function

Mentioned in ?

References in periodicals archive ?

The partnership will focus on the delivery of recombinant Glial Cell Line-Derived Neurotrophic Factor (GDNF) to affected brain regions by way of implanted, encapsulated cell therapy devices.

Japan : Takeda and NsGene Partner to Perform Research in Cell Encapsulation Therapies for Parkinson's Disease

Neurotech Pharmaceuticals Inc, a biotechnology company focused on developing transformative therapies for chronic eye diseases, revealed on Monday that the US Food and Drug Administration (FDA) has accepted Neurotech's ability to proceed with its Investigational New Drug (IND) application to conduct a Phase 2 clinical study of NT-503 Encapsulated Cell Therapy (ECT).

Neurotech IND application and clinical trial initiation of novel therapy for wet AMD accepted by FDA

And Thomas Chang's laboratory at McGill University pioneered encapsulated cell therapy for liver failure and as an artificial red blood cell.

Some examples include research out of the laboratory of Michael Sefton, FCIC, where encapsulated cell therapy was investigated to overcome diabetes and Parkinson's disease.

Crossing over--the promise of regenerative medicine: healing is redefined at the University of Toronto. Innovative strategies inspire collaborative enterprises

We are pleased the encapsulated cell therapy being developed is being recognized by the scientific and medical community," said Dr.

Nuvilex Treatment Approach Receives Endorsement in Major Industry Publications and Clinical Trial Planning Moves Forward

NT-501 is designed to continually deliver a therapeutic dose of CNTF directly to the back of the eye in a controlled, continuous manner by means of the Company's proprietary Encapsulated Cell Therapy (ECT) platform.

Neurotech's core technology platform is Encapsulated Cell Therapy (ECT), a unique technology that allows for the long-term, sustained delivery of therapeutic factors to the back of the eye.

Neurotech's NT-501 Implant Demonstrates Statistically Significant Photoreceptor Preservation in Patients with Retinal Degenerative Disease

NT-501 is designed to continually deliver a therapeutic dose of CNTF into the back of the eye in a controlled, continuous basis by means of the Company's proprietary Encapsulated Cell Therapy (ECT) platform.

Neurotech's NT-501 Implant Slows Vision Loss in Patients with Geographic Atrophy Associated with Dry AMD as Reported in PNAS

Full browser ?

CITE

Site: Follow: Share:

Open / Close